glp-1 bmi 25 and Weight Loss Treatment: What BMI Qualifies? P181 Glucagon-like peptide-1 receptor agonist
Description
Conclusion Maximizing the benefits of GLP-1 therapies require a multidisciplinary approach that integrates evidence-based nutrition, physical activity, and proactive management of gastrointestinal side effects
Olshansky et al., 2005)
Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, et al
J Diabetes (2015) 7(4):5848.10.1111/1753-0407.12282 28 SunHXLuNLiuDMZhaoLSunLHZhaoHYet alThe bone-preserving effects of exendin-4 in ovariectomized rats
Arterioscler Thromb Vasc Biol (2020) 40(3):50622
